Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triple P study of postoperative pain control after pancreaticoduodenectomy
NL-OMON55379Phase 4Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Oct 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sufentanil, morphine and ropivacaine in postoperative pain (3 arms), sponsored by Leiden University Medical Center. Primary endpoints: Mean pain score during postoperative days 1-3 and Mean daily pain satisfaction during postoperative days 1-3. Started Oct 2018; status: active, not recruiting.
02
Drugs
sufentanilmorphineropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NL-OMON55379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55379.